Genetic test regulation problems loom on the horizon?
This article was originally published in Clinica
Executive Summary
Problems could lie ahead for the US in its efforts to regulate genetic tests, according to a highly-respected Washington attorney. Jonathan Kahan, an attorney in the law firm of Hogan & Hartson, told last week's annual meeting of the Association of Medical Diagnostic Manufacturers that the FDA's current regulatory approach is "unworkable."